Viruses,
Год журнала:
2023,
Номер
15(7), С. 1545 - 1545
Опубликована: Июль 13, 2023
COVID-19
has
infected
humans
worldwide,
causing
millions
of
deaths
or
prolonged
symptoms
in
survivors.
The
transient
persistent
after
SARS-CoV-2
infection
have
been
defined
as
post-COVID-19
conditions
(PCC).
We
conducted
a
study
151
Brazilian
PCC
patients
to
analyze
and
immunoglobulin
profiles,
taking
into
account
sex,
vaccination,
hospitalization,
age.
Fatigue
myalgia
were
the
most
common
symptoms,
lack
neuropsychiatric
metabolic
comorbidities
relevant
development
PCC.
Analysis
serological
immunoglobulins
showed
that
IgA
was
higher
patients,
especially
adult
elderly
groups.
Also,
non-hospitalized
hospitalized
produced
high
similar
levels
IgA.
Our
results
indicated
detection
antibodies
against
during
course
disease
could
be
associated
with
may
an
immunological
signature
predict
patients.
Scientific Reports,
Год журнала:
2023,
Номер
13(1)
Опубликована: Июль 11, 2023
There
has
been
an
increasing
interest
in
the
long-term
impact
of
long
COVID.
However,
only
a
few
studies
have
investigated
clinical
manifestations
COVID
after
24
months
acute
infection.
In
this
study,
prospective
online
surveys
were
conducted
adults
previously
diagnosed
with
coronavirus
disease
2019
(COVID-19)
South
Korea
between
February
13
and
March
13,
2020,
at
6,
12,
COVID-19.
We
self-reported
symptoms
EuroQol-5-dimension
index.
Among
900
individuals
enrolled
initially,
150
completed
all
3
surveys.
After
excluding
cases
COVID-19
reinfection,
132
included
final
analysis.
participants,
94
(71.2%)
experienced
The
most
frequently
reported
fatigue
(34.8%),
amnesia
(30.3%),
concentration
difficulties
(24.2%),
insomnia
(20.5%),
depression
(19.7%).
Notably,
no
significant
differences
noted
incidence
terms
number
vaccinations
received.
Although
neuropsychiatric
quality
life
improved
over
time,
it
continued
to
affect
32.7%
participants.
Symptoms
COVID,
particularly
symptoms,
tend
persist
vaccination
or
received
may
not
significantly
Biology,
Год журнала:
2023,
Номер
12(5), С. 735 - 735
Опубликована: Май 18, 2023
A
large
amount
of
published
research
points
to
the
interesting
concept
(hypothesis)
that
magnesium
(Mg)
status
may
have
relevance
for
outcome
COVID-19
and
Mg
could
be
protective
during
COVID
disease
course.
As
an
essential
element,
plays
basic
biochemical,
cellular,
physiological
roles
required
cardiovascular,
immunological,
respiratory,
neurological
functions.
Both
low
serum
dietary
been
associated
with
severity
outcomes,
including
mortality;
both
are
also
risk
factors
such
as
older
age,
obesity,
type
2
diabetes,
kidney
disease,
cardiovascular
hypertension,
asthma.
In
addition,
populations
high
rates
mortality
hospitalization
tend
consume
diets
in
modern
processed
foods,
which
generally
Mg.
this
review,
we
review
describe
consider
possible
impact
on
showing
(1)
between
2.19
2.26
mg/dL
intakes
>
329
mg/day
course
(2)
inhaled
improve
oxygenation
hypoxic
patients.
spite
promise,
oral
has
thus
far
studied
only
combination
other
nutrients.
deficiency
is
involved
occurrence
aggravation
neuropsychiatric
complications
COVID-19,
memory
loss,
cognition,
loss
taste
smell,
ataxia,
confusion,
dizziness,
headache.
Potential
zinc
and/or
useful
increasing
drug
therapy
effectiveness
or
reducing
adverse
effect
anti-COVID-19
drugs
reviewed.
Oral
trials
patients
warranted.
Frontiers in Public Health,
Год журнала:
2023,
Номер
10
Опубликована: Янв. 4, 2023
Electronic
sports
(esports)
has
become
a
practical
intervention
for
young
people
craving
social
connections
since
the
COVID-19
pandemic.
Past
studies
have
shown
an
equivocal
role
of
esports
participation
in
boosting
ties
or
connectedness.
It
is
unclear
if
their
relationship
affected
by
subjective
attitudes
gamers.
Moreover,
present
pandemic
may
further
modify
this
to
greater
extent.
Frontiers in Behavioral Neuroscience,
Год журнала:
2024,
Номер
18
Опубликована: Фев. 6, 2024
Background
Neurexins,
essential
synaptic
proteins,
are
linked
to
neurodevelopmental
and
neuropsychiatric
disorders
like
autism
spectrum
disorder
(ASD)
schizophrenia.
Objective
Through
this
systematic
review,
we
aimed
shed
light
on
the
relationship
between
neurexin
dysfunction
its
implications
in
manifestations.
Both
animal
human-induced
pluripotent
stem
cell
(hiPSC)
models
served
as
our
primary
investigative
platforms.
Methods
Utilizing
PRISMA
2020
guidelines,
search
strategy
involved
scouring
articles
from
PubMed
Google
Scholar
databases
covering
a
span
of
two
decades
(2003–2023).
Of
initial
collection,
27
rigorously
evaluated
studies
formed
essence
review.
Results
Our
review
suggested
significant
ties
anomalies
outcomes,
most
notably
ASD.
Rodent-based
investigations
delineated
pronounced
ASD-associated
behaviors,
hiPSC
derived
ASD-diagnosed
patients
revealed
disruptions
calcium
dynamics
activities.
Additionally,
underlined
integral
role
specific
variants,
primarily
NRXN1,
pathology
It
was
also
evident
observation
that
malfunctions
were
implicated
broader
array
these
disorders,
including
ADHD,
intellectual
challenges,
seizure
disorders.
Conclusion
This
accentuates
cardinal
neurexins
play
pathological
process
The
findings
underscore
critical
need
for
standardized
methodologies
developing
future
studies,
aiming
minimize
heterogeneity.
Moreover,
highlight
expand
research
into
less
studied
variants
(i.e.,
NRXN2
NRXN3),
broadening
scope
understanding
field.
projects
potent
tools
bridging
gaps,
promoting
translational
research,
fostering
development
patient-specific
therapeutic
interventions.
Abstract
Background
&
Objectives
Objective
assessment
of
post-COVID-19
cognitive
dysfunction
is
highly
warranted.
This
study
aimed
to
evaluate
the
COVID-19
survivors
with
complaints,
both
clinically
and
neurophysiologically,
using
Quantitative
Electroencephalogram
(QEEG).
Methods
case–control
was
conducted
on
50
recovered
subjects
from
infection
complaints
age,
sex,
educational-matched
healthy
controls.
Both
groups
were
subjected
following
neurocognitive
tests:
Paired
associate
learning
Test
(PALT)
Paced
Auditory
Serial
Addition
(PASAT).
The
neurophysiological
also
done
for
QEEG.
Results
had
significantly
lower
PALT
scores
than
controls
(
P
<
0.001).
QEEG
analysis
found
higher
levels
Theta
/
Beta
ratio
in
central
parietal
areas
patients
0.001
each).
interhemispheric
coherence
frontal,
central,
regions
control
group
regarding
alpha
beta
bands.
There
statistically
significant
PASAT
among
cases
severe
=
0.011,
0.005
,
respectively)
those
who
needed
oxygen
support
0.04,
0.01,
respectively).
On
other
hand,
a
mean
frontal
inter-hemispheric
0.01)
needing
mechanical
ventilation
0.04).
Conclusion
Episodic
memory
deficit
evident
subjective
accompanied
by
regions.
These
clinical
changes
are
associated
hypoxia
severity.
Abstract
Background
The
relationship
between
COVID-19
infection
and
a
possible
increased
likelihood
of
older
adults
developing
new-onset
dementia
(NOD)
remains
elusive.
Methods
A
thorough
search
was
performed
across
several
databases
including
MEDLINE/PubMed,
PsycINFO,
Scopus,
medRxiv,
PQDT
Global
for
studies
published
in
English
from
January
2020
to
December
2023.
Only
original
investigations
exploring
the
link
NOD
were
selected
inclusion.
We
assessed
risk
NOD,
using
Risk
Ratio
(RR)
measurement.
Control
groups
categorized
as:
(i)
non-COVID
cohort
with
other
respiratory
infections
[control
group
(C1)];
(ii)
otherwise
unspecified
health
status
(C2)].
Follow-up
periods
divided
into
intervals
3,
6,
12,
24
months
post-COVID.
Results
11
(involving
939,824
post-COVID-19
survivors
6,765,117
controls)
included
review.
Across
median
observation
period
12
post-COVID,
overall
incidence
about
1.82%
COVID-infected
group,
compared
0.35%
non-COVID-infected
group.
pooled
meta-analysis
showed
significantly
among
adult
non-COVID-19
controls
(RR
=
1.58,
95%
CI
1.21–2.08).
Similar
risks
observed
subgroup
analyses
restricted
an
observational
1.56,
1.21–2.01),
as
well
five
that
employed
propensity
score
matching
sufficiently
effectively
control
multiple
confounding
covariates
1.46,
1.10–1.94).
C1
shared
comparably
(overall
RR
1.13,
0.92–1.38).
Discussion
Under
normal
circumstances,
we
believe
is
likely
be
factor
over
time.
While
due
appears
similar
associated
infections,
it
warrants
necessitates
investigation
longer
observations.
European Archives of Psychiatry and Clinical Neuroscience,
Год журнала:
2024,
Номер
unknown
Опубликована: Май 13, 2024
Abstract
Cognitive
symptoms
(CS)
belong
to
the
most
common
manifestations
of
Post
COVID-19
(PC)
condition.
We
sought
objectify
CS
in
PC
patients
using
routine
diagnostic
assessments:
neurocognitive
testing
(NCT)
and
brain
imaging
(BI).
Further,
we
investigated
possible
associations
with
patient
reported
outcomes
(PROs),
risk
factors
for
developing
CS.
Clinical
data
PROs
315
were
assessed
at
a
mean
6
months
after
SARS-CoV-2
infection.
231
(73.3%)
any
sort
Among
them,
78
underwent
NCT
55
received
BI.
In
NCT,
cognitive
domains
affected
working
memory,
attention,
concentration.
Nonetheless,
pathological
thresholds
exceeded
only
few
cases.
Neurocognitive
performance
did
not
differ
significantly
between
complaining
severe
(n
=
26)
versus
non-severe
52)
BI
findings
abnormal
8
(14.5%)
cases
but
likely
related
PC.
Patients
reporting
high
severity
scored
worse
PHQ-9,
FSS,
WHOQOL-BREF,
more
report
impaired
sleep,
had
higher
prevalence
psychiatric
diagnoses.
Overall,
could
confirm
mild
impairment
some
all
CS,
while
studies
affect
results,
associated
depression
(PHQ-9),
fatigue
(FSS),
reduced
quality
life
(WHOQOL-BREF)
illnesses.
These
support
importance
BI,
neuro-psychological
assessment
work-up
Trial
registration
number
date
registration:
DRKS00030974,
22
Dec
2022,
retrospectively
registered.
Healthcare,
Год журнала:
2025,
Номер
13(2), С. 196 - 196
Опубликована: Янв. 19, 2025
Background/Objectives:
Among
the
neuropsychiatric
symptoms
of
long
COVID,
following
may
be
listed:
sleep
disturbances,
headaches,
anxiety,
depression,
dizziness,
numbness,
memory
loss,
and
concentration
difficulties.
Various
therapies
have
been
implemented
to
mitigate
these
symptoms;
however,
health
resort
treatments
that
utilize
a
wide
range
modalities
stimulating
multidirectional
biological
reactions
also
effective.
The
aim
this
study
was
assess
severity
in
COVID
patients
who
qualified
for
treatment,
evaluate
effectiveness
treatment
group
patients,
effect
balneological
factors
course.
Methods:
A
retrospective
analysis
medical
records
120
people
with
(69
women
51
men)
aged
42–79
underwent
2021
performed.
People
were
eligible
at
lowland
based
on
valid
referral
from
doctor.
included
therapies,
physical
medicine
modalities,
exercise
programs,
education,
psychological
support.
Patients
assessed
persistent
0–10
point
scale
before
after
treatment.
Results:
After
greatest
improvement
noted
disorders
(2.47
±
2.23
points
vs.
0.86
1.25
points,
p
<
0.00001)
dizziness
(1.39
1.94
0.34
0.76
0.00001).
lowest
observed
(2.68
2.5
1
1.4
Conclusions:
reported
mild
symptoms.
Health
mitigates
symptoms,
as
it
is
complex
approach.
Treatment
includes
improves
greater
extent.
This
method
should
integrated
into
standard
COVID.